The stability of Pt-based catalysts is critical to the reliability of proton exchange membrane fuel cells. Here, the authors use stroboscopic operando high energy X-ray scattering to reveal Pt ...

MUNIS lays the foundation for applications in cancer T cell immunotherapy and autoimmunity research. As the global community continues to confront emerging infectious diseases, tools like MUNIS offer ...

has unveiled an innovative solid oxide fuel cell (SOFC) system powered by ammonia (NH 3) for all-electric ships. This research, published in Frontiers in Energy, offers a highly efficient and ...

With 14% of all greenhouse gases coming from fossil fuel chemical synthesis, cell factories offer an alternative which could help the U.K. government meet the target of net zero by 2050.

Findings showed acalabrutinib with bendamustine and rituximab (BR) reduced the risk of disease progression or death by 27% compared with placebo plus BR. The Food and Drug Administration (FDA) has ...

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. When burned or used in fuel cells, hydrogen produces nothing but water, making it an ...

FDA fully approves AstraZeneca's Calquence combo therapy, reducing MCL progression ... Next: Access Our New, Shockingly Simple 'Alert System' Mantle cell lymphoma (MCL) is a rare and typically ...

A team of scientists from South Korea is working to lower the cost and boost the durability of promising proton exchange membrane fuel cells by doping expensive platinum-cobalt catalysts with nitrogen ...

AP Moller-Maersk aims to have at least 19 dual-fuel methanol vessels in operation by the end of this year. “This year, we need regulations from the International Maritime Organization (IMO) to close ...

The Food and Drug Administration (FDA) has granted traditional approval to Calquence (acalabrutinib) with bendamustine and Rituxan (rituximab) for adults with previously untreated mantle cell lymphoma ...